However, neutrophils from patients with chronic granulomatous disease (CGD), which have mutations in components of the NADPH oxidase and thereby do not produce ROS, were equally capable of killing antibody-opsonized cancer cells compared to neutrophils from healthy donors [64,65,86]. The gene discussed is FMO5; the disease is chronic granulomatous disease.